X

Company profile for SUNBIO INC

SUNBIO INC

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

No Presentations

VIDEO(s)

No Video

DIGITAL CONTENT

No Content

APIs // Active Pharmaceutical Ingredients

7 APIs, 7 USDMF

DEVELOPMENTS

No Content

Contact Supplier

Related Companies

SUNBIO, INC.

SunBio is a biotech company developing biosimilars, biopharmaceuticals, and medical devices based on our proprietary technologies of pegylation. SunBio’s biosimilar product, PEG-filgrastim, has been marketed in EU (under the tradename Pelgraz) and Canada (under the tradename Lapelga) since 2018, and in India (under the tradename NeuPEG) since 2008. SunBio’s medical device for treatment of dry mouth syndrome, MucoPEG, ...

SunBio is a biotech company developing biosimilars, biopharmaceuticals, and medical devices based on our proprietary technologies of pegylation. SunBio’s biosimilar product, PEG-filgrastim, has been marketed in EU (under the tradename Pelgraz) and Canada (under the tradename Lapelga) since 2018, and in India (under the tradename NeuPEG) since 2008. SunBio’s medical device for treatment of dry mouth syndrome, MucoPEG, received FDA clearance for US marketing in November 2019.